FDA NDC Directory · JSON-LD · Markdown

Everolimus

NDC 67877-718 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214138
Dosage form / routeTABLET · ORAL
Active ingredientsEVEROLIMUS (.25 mg/1)
Marketing started20211127
Package count2

External sources

Source: openFDA. Public-domain (CC0).